Retractable Technologies Inc (RVP)
0.758
+0.04
(+5.13%)
USD |
NYAM |
Sep 27, 16:00
0.7502
-0.01
(-1.03%)
After-Hours: 20:00
Retractable Technologies Research and Development Expense (Annual): 0.5812M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.5812M |
| December 31, 2022 | 0.5257M |
| December 31, 2021 | 0.9014M |
| December 31, 2020 | 0.5745M |
| December 31, 2019 | 0.5161M |
| December 31, 2018 | 0.6214M |
| December 31, 2017 | 0.7406M |
| December 31, 2016 | 0.5718M |
| December 31, 2015 | 0.6075M |
| December 31, 2014 | 0.6168M |
| December 31, 2013 | 0.8371M |
| December 31, 2012 | 0.8719M |
| Date | Value |
|---|---|
| December 31, 2011 | 0.815M |
| December 31, 2010 | 0.8854M |
| December 31, 2009 | 1.031M |
| December 31, 2008 | 1.066M |
| December 31, 2007 | 1.071M |
| December 31, 2006 | 0.9588M |
| December 31, 2005 | 0.9342M |
| December 31, 2004 | 0.6269M |
| December 31, 2003 | 0.5611M |
| December 31, 2002 | 0.3379M |
| December 31, 2001 | 0.7565M |
| December 31, 2000 | 0.8991M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
0.5161M
Minimum
2019
0.9014M
Maximum
2021
0.6198M
Average
0.5745M
Median
2020
Research and Development Expense (Annual) Benchmarks
| Plus Therapeutics Inc | 9.69M |
| Perspective Therapeutics Inc | 21.31M |
| InfuSystems Holdings Inc | -- |
| Xtant Medical Holdings Inc | 1.336M |
| Catheter Precision Inc | 0.475M |